Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Asset Utilization Ratio (2016 - 2025)

Voyager Therapeutics' Asset Utilization Ratio history spans 11 years, with the latest figure at 0.15 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 14.54% year-over-year to 0.15; the TTM value through Dec 2025 reached 0.15, up 14.54%, while the annual FY2025 figure was 0.13, 41.79% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.15 at Voyager Therapeutics, up from 0.1 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.77 in Q4 2023 and bottomed at 0.08 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.25 (2024), against an average of 0.33.
  • The largest annual shift saw Asset Utilization Ratio crashed 88.4% in 2021 before it soared 409.51% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.2 in 2021, then rose by 21.1% to 0.24 in 2022, then skyrocketed by 223.42% to 0.77 in 2023, then plummeted by 83.15% to 0.13 in 2024, then grew by 14.54% to 0.15 in 2025.
  • Per Business Quant, the three most recent readings for VYGR's Asset Utilization Ratio are 0.15 (Q4 2025), 0.1 (Q3 2025), and 0.13 (Q2 2025).